Blog: ORTHOFIX MEDICAL INC. : Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) – Marketscreener.com

Item 2.02. Results of Operations and Financial Condition.

On August 5, 2022, Orthofix Medical Inc. (the “Company”) issued a press release
announcing, among other things, its financial results for the second quarter
ended June 30, 2022. A copy of the press release is furnished herewith as
Exhibit 99.1 and attached hereto.

The information furnished in this Item 2.02, including the exhibit furnished
herewith as Exhibit 99.1, will not be treated as “filed” for the purposes of
Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), or otherwise subject to the liabilities of that section. This information
will not be deemed incorporated by reference into any filing under the
Securities Act of 1933, as amended (the “Securities Act”), or into another
filing under the Exchange Act, unless that filing expressly incorporates by
reference this Item 2.02 of this report.

Item 7.01 Regulation FD Disclosure.

The press release furnished in Exhibit 99.1 also provides an update on the
Company’s business outlook, that is intended to be within the safe harbor
provided by the Private Securities Litigation Reform Act of 1995 (the “Act”) as
comprising forward looking statements within the meaning of the Act.

The information furnished in this Item 7.01, including the exhibit furnished
herewith as Exhibit 99.1, will not be treated as “filed” for the purposes of
Section 18 of the Exchange Act, or otherwise subject to the liabilities of that
section. This information will not be deemed incorporated by reference into any
filing under the Securities Act, or into another filing under the Exchange Act,
unless that filing expressly incorporates by reference this Item 7.01 of this
report.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

99.1   Press release, dated August 5, 2022
104  Cover Page Interactive Data File (embedded within the Inline XBRL document).

——————————————————————————–

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

Orthofix Medical Inc.

By:   /s/ Kimberley A. Elting
      Kimberley A. Elting
      President, Global Orthopedics

      Chief Legal and Development Officer





Date: August 5, 2022

——————————————————————————–

© Edgar Online, source Glimpses